Abstract: A contact lens travel device having a flexible body is provided. The body of the device is configurable to a circular configuration wherein fasteners engaged with opposing ends of the body compressively engage the body encircled around an eyeglass case. So engaged, the device is positionable as a stand for a mirror at multiple angles above a support surface for a user to employ for contact lens insertion or removal from their eyes. A fluid container is engageable within a pocket of the body with a cap end of the container extending from the perimeter to allow for dispensing of eye drops therefrom without removal of the container from the pocket.

Abstract: A contact lens travel device having a flexible body is provided. The body of the device is configurable to a circular configuration wherein fasteners engaged with opposing ends of the body compressively engage the body encircled around an eyeglass case. So engaged, the device is positionable as a stand for a mirror at multiple angles above a support surface for a user to employ for contact lens insertion or removal from their eyes. A fluid container is engageable within a pocket of the body with a cap end of the container extending from the perimeter to allow for dispensing of eye drops therefrom without removal of the container from the pocket.

Abstract: A contact lens travel device is provide having a flexible body. The body of the device is configurable to a circular configuration wherein it is adapted to engage an eyeglass case or for a positioning as support for a mirror at multiple angles above a support surface for a user to employ for contact lens insertion or removal from their eyes. A fluid container is engageable within a pocket of the body with a cap end of the container extending from the perimeter to allow for dispensing of eye drops therefrom without removal of the container from the pocket.

Abstract: The present disclosure is directed to compositions and methods for formulating a pharmaceutical dosage form by forming a composition comprising acetyl-11-keto-?-boswellic acid, diindolylmethane, or curcumin with one or more pharmaceutically acceptable excipients for enhanced solubility to increase bioavailability and improve therapeutic efficacy. The composition can be processed by thermo-kinetic compounding along with conventional methods known in the art, such as hot melt extrusion, melt granulation, compression molding, tablet compression, capsule filling, film-coating, or injection molding.